NetDr.com Since 1998 source for: Viagra [ sildenafil citrate ], Propecia/Proscar [ finasteride ], Cialis and Levitra.

Cart | Login

Medications

Hair Loss

Weight Loss

Xenical

Cosmetic

Latisse

Sexual Health

Skin Care

Finding More Than You May Need to Know 2007-05-01

By Gina Kolata

WHEN George Skouras, an investment manager in New York, turned 52, he decided to go for a complete physical exam. He felt perfectly healthy, but wanted to know if there was anything to worry about.

Arcoxia Request Rejected 2007-04-28

By NY Times

The Food and Drug Administration rejected Merck & Company's request to market a successor to its withdrawn arthritis drug Vioxx in the United States, the drug maker said. The decision was widely expected, after a panel of F.D.A. advisers two weeks

Erectile Function, Sexual Drive, And Ejaculatory Function Analyzed After Reconstructive Surgery 2007-04-27

By Science Daily

There are few studies that address the subject of sexual function after reconstructive surgery for anterior urethral stricture disease.

Erectile Function, Sexual Drive, And Ejaculatory Function Analyzed After Reconstructive Surgery 2007-04-27

By Science Daily

There are few studies that address the subject of sexual function after reconstructive surgery for anterior urethral stricture disease.

One-Third Of Sexually Active Older Adults With HIV/AIDs Has Unprotected Sex 2007-04-26

By Science Daily

One out of three sexually active older adults infected with HIV has unprotected sex, according to a study by Ohio University researchers.

One-Third Of Sexually Active Older Adults With HIV/AIDs Has Unprotected Sex 2007-04-26

By Science Daily

One out of three sexually active older adults infected with HIV has unprotected sex, according to a study by Ohio University researchers.

Three Most Common Prostate Cancer Treatments Impact Men In Different Ways 2007-04-25

By Science Daily

A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways.

Three Most Common Prostate Cancer Treatments Impact Men In Different Ways 2007-04-25

By Science Daily

A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways.

Three Most Common Prostate Cancer Treatments Impact Men In Different Ways 2007-04-25

By Science Daily

A rigorous, long-term study of quality of life in patients who underwent one of the three most common treatments for prostate cancer found that each affected men's lives in different ways.

1/3 of sexually active older adults with HIV/AIDs has unprotected sex 2007-04-24

By Andrea Gibson

Findings suggest more prevention efforts may be needed

A Medical Journal Punishes a Cardiologist for Allegedly Violating a Cardinal Rule 2007-04-23

By Barnaby Feder

Among medical journals, the release of articles expected to make national headlines is an art form as carefully choreographed as kabuki. Which is why anyone who does not stay in step may be asked to sit down.

Missed Signals 2007-04-22

By Lisa Sanders

The emergency technicians burst through the doors, pushing a stretcher into the crowded E.R. Their walkie-talkies dangled from their shoulders, squawking and hissing like demented parrots.

The Science of Attacking Cholesterol 2007-04-14

By William Holstein

The Science of Attacking Cholesterol

F.D.A. Rejects Merck’s New Pain Medication 2007-04-13

By Gardiner Harris

A panel of federal drug advisers voted 20 to 1 Thursday to reject an application by Merck to sell its pain pill Arcoxia because of concerns that the drug could cause as many as 30,000 heart attacks annually if widely used.

Merck Reports Risk of Its New Pain Pill 2007-04-11

By NY Times

A study by Merck of its pain reliever Arcoxia showed similar risks of heart attacks and other cardiovascular problems compared with another painkiller, diclofenac, federal reviewers said in an analysis made public Tuesday.

PSA doubling predicts prostate cancer recurrence 2007-04-09

By John Murphy

A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time (DT) is found to be a reliable tool to distinguish which

It’s Not a ‘Plumbing Problem’ 2007-04-08

By Gina Kolata

It’s Not a ‘Plumbing Problem’

Lessons of Heart Disease, Learned and Ignored 2007-04-08

By Gina Kolata

Keith Orr thought he would surprise his doctor when he came for a checkup.

Health Risk to Older Women Is Seen in Hormone Therapy 2007-04-04

By Gina Kolata

A new analysis of combined data from two parts of a large federal study of hormone therapy has found that women in their 50s do not appear to have an increased heart attack risk if they take the drugs. But it also found that women in their 60s and 70s

PSA is poor predictor of lethal prostate cancer 2007-04-03

By Liz Savage

The amount of prostate-specific antigen (PSA) in a man’s bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease does not adequately predict lethal prostate cancer, according to a study in the

READ MORE

<<... <... 618 619 620 621 622 623 624 625 626 627 ...> ...>>

Patent Pending: 60/481641

Email Us

About Us Privacy Policy Doctor Login